These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 35879137

  • 1. Subclinical inflammation as a predictor for erectile dysfunction after brachytherapy for localized prostate cancer.
    Garabed LR, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2022; 21(6):864-869. PubMed ID: 35879137
    [Abstract] [Full Text] [Related]

  • 2. Favorable preservation of erectile function after prostate brachytherapy for localized prostate cancer.
    Bazinet A, Zorn KC, Taussky D, Delouya G, Liberman D.
    Brachytherapy; 2020; 19(2):222-227. PubMed ID: 31837989
    [Abstract] [Full Text] [Related]

  • 3. The interaction between inflammation, urinary symptoms and erectile dysfunction in early-stage prostate cancer treated with brachytherapy.
    Alcaidinho A, Nguyen DD, Delouya G, Zorn KC, Saad F, Taussky D, Liberman D.
    Andrologia; 2021 Jul; 53(6):e14070. PubMed ID: 33852165
    [Abstract] [Full Text] [Related]

  • 4. Dose to the penile bulb and individual patient anatomy are predictive of erectile dysfunction in men treated with 125I low dose rate brachytherapy for localized prostate cancer.
    Chasseray M, Dissaux G, Bourbonne V, Boussion N, Goasduff G, Malloreau J, Malhaire JP, Fournier G, Tissot V, Pradier O, Valeri A, Schick U.
    Acta Oncol; 2019 Jul; 58(7):1029-1035. PubMed ID: 30761939
    [Abstract] [Full Text] [Related]

  • 5. Effect of aging and long-term erectile function after iodine-125 prostate brachytherapy.
    Keyes M, Pickles T, Crook J, McKenzie M, Cheung A, Spadinger I, LaPointe V, Bachand WF, Morris J.
    Brachytherapy; 2015 Jul; 14(3):334-41. PubMed ID: 25684438
    [Abstract] [Full Text] [Related]

  • 6. [Erectile dysfunction evaluation after brachytherapy for low risk prostate adenocarcinoma: prospective study of patients with a baseline IIEF5>16].
    Delage F, Perrouin-Verbe MA, Le Fur E, Papin G, Thoulouzan M, Malhaire JP, Pradier O, Fournier G, Valéri A.
    Prog Urol; 2015 Feb; 25(2):68-74. PubMed ID: 25497176
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Erectile function after prostate brachytherapy.
    Merrick GS, Butler WM, Wallner KE, Galbreath RW, Anderson RL, Kurko BS, Lief JH, Allen ZA.
    Int J Radiat Oncol Biol Phys; 2005 Jun 01; 62(2):437-47. PubMed ID: 15890585
    [Abstract] [Full Text] [Related]

  • 9. Radiation dose to the neurovascular bundles or penile bulb does not predict erectile dysfunction after prostate brachytherapy.
    Kiteley RA, Lee WR, deGuzman AF, Mirzaei M, McCullough DL.
    Brachytherapy; 2002 Jun 01; 1(2):90-4. PubMed ID: 15062176
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Erectile function after permanent prostate brachytherapy.
    Merrick GS, Butler WM, Galbreath RW, Stipetich RL, Abel LJ, Lief JH.
    Int J Radiat Oncol Biol Phys; 2002 Mar 15; 52(4):893-902. PubMed ID: 11958881
    [Abstract] [Full Text] [Related]

  • 12. Risk of erectile dysfunction after modern radiotherapy for intact prostate cancer.
    Hunt AA, Choudhury KR, Nukala V, Nolan MW, Ahmad A, Ashcraft KA, Koontz BF.
    Prostate Cancer Prostatic Dis; 2021 Mar 15; 24(1):128-134. PubMed ID: 32647352
    [Abstract] [Full Text] [Related]

  • 13. The Natural History of Erectile Dysfunction After Prostatic Radiotherapy: A Systematic Review and Meta-Analysis.
    Gaither TW, Awad MA, Osterberg EC, Murphy GP, Allen IE, Chang A, Rosen RC, Breyer BN.
    J Sex Med; 2017 Sep 15; 14(9):1071-1078. PubMed ID: 28859870
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A prospective longitudinal survey of erectile dysfunction in patients with localized prostate cancer treated with permanent prostate brachytherapy.
    Matsushima M, Kikuchi E, Maeda T, Nakashima J, Sugawara A, Ando T, Mizuno R, Nagata H, Miyajima A, Shigematsu N, Oya M.
    J Urol; 2013 Mar 15; 189(3):1014-8. PubMed ID: 23017516
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Prevalence of Baseline Erectile Dysfunction (ED) in an Australian Cohort of Men with Localized Prostate Cancer.
    Ong WL, McLachlan H, Millar JL.
    J Sex Med; 2015 May 15; 12(5):1267-74. PubMed ID: 25847707
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer.
    Kollmeier MA, Fidaleo A, Pei X, Cohen G, Zaider M, Mo Q, Cox B, Yamada Y, Zelefsky MJ.
    BJU Int; 2013 Jun 15; 111(8):1231-6. PubMed ID: 23551568
    [Abstract] [Full Text] [Related]

  • 20. Reporting Erectile Function Outcomes After Radiation Therapy for Prostate Cancer: Challenges in Data Interpretation.
    Wortel RC, Incrocci L, Mulhall JP.
    J Sex Med; 2017 Oct 15; 14(10):1260-1269. PubMed ID: 28965787
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.